Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

EXACT SCIENCES CORP Denmark Finland France Germany Netherlands Sweden United Kingdom Wisconsin

Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimatesNew concordance analysis supporting the generation of Oncotype DX® results from core needle biopsy to personalize treatment decisionsADAPTcycle trial data, using Oncotype DX results and endocrine response to stratify patients, may expand the number of breast cancer patients able to forgo chemotherapy post-surgery; data chosen as late-breaking abstractProspective trial data regarding the potential omission of radiation therapy after surgery in certain patients with ductal carcinoma in situ (DCIS) chosen for press program 

 

View original content:https://www.prnewswire.co.uk/news-releases/exact-sciences-presents-multiple-studies-at-san-antonio-breast-cancer-symposium-supporting-optimization-and-individualization-of-therapy-for-breast-cancer-patients-302002568.html